IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0069944.html
   My bibliography  Save this article

Tocilizumab Induced Acquired Factor XIII Deficiency in Patients with Rheumatoid Arthritis

Author

Listed:
  • Sho Mokuda
  • Yosuke Murata
  • Naoya Sawada
  • Kenichiro Matoba
  • Akihiro Yamada
  • Makoto Onishi
  • Yasuaki Okuda
  • Kazuo Jouyama
  • Eiji Sugiyama
  • Kiyoshi Takasugi

Abstract

Factor XIII is one of the twelve coagulation factors and also known as a fibrin-stabilizing factor. In 2012, we encountered a male RA patient with hemorrhagic factor XIII deficiency who had been treated with tocilizumab for two years. There are few reports regarding the relationship between tocilizumab (a humanized monoclonal antibody against the interleukin-6 receptor (IL-6R)) and factor XIII. We measured the factor XIII activity levels in the plasma of 40 RA patients (10 patients treated without biologics, 30 patients treated with biologics (15 patients treated with necrosis factor inhibitors and 15 patients treated with tocilizumab)) and 19 healthy controls. Consequently, the tocilizumab group exhibited lower levels than the other three groups according to the Steel-Dwass test (P

Suggested Citation

  • Sho Mokuda & Yosuke Murata & Naoya Sawada & Kenichiro Matoba & Akihiro Yamada & Makoto Onishi & Yasuaki Okuda & Kazuo Jouyama & Eiji Sugiyama & Kiyoshi Takasugi, 2013. "Tocilizumab Induced Acquired Factor XIII Deficiency in Patients with Rheumatoid Arthritis," PLOS ONE, Public Library of Science, vol. 8(8), pages 1-6, August.
    • Handle: RePEc:plo:pone00:0069944
    DOI: 10.1371/journal.pone.0069944
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0069944
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0069944&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0069944?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0069944. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.